Journal of Cardiovascular Pharmacology · 2017 · 16 citations · 13 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyElectrophysiologySleep MedicineAntiarrhythmic TherapyArrhythmia PharmacotherapyCardiac ArrhythmiasCardiac MedicationsCardiac PharmacotherapySleep Disorder PharmacotherapyAntiarrhythmic PharmacologyLife-threatening ArrhythmiasMelatonin SupplementationMelatonin TreatmentSleepSleep Disorder MedicationsSymptomatic PresentationVentricular Arrhythmia Pharmacotherapy
Idiopathic ventricular arrhythmias (IVAs) are relatively common in the general population and usually have a good prognosis. However, frequent premature ventricular contractions (PVCs) can lower the quality of life (in symptomatic cases) and can cause cardiomyopathy and sudden cardiac death. In this report, we demonstrate a novel trigger for IVAs. Melatonin use for treating sleep disorders has increased significantly in recent years. We provide here the first human evidence of its proarrhythmic effect by presenting 2 patients (with normal myocardium) with symptomatic PVCs, while on melatonin. Discontinuation of melatonin stopped PVCs in both patients. Our findings highlight the importance of identifying precipitating factors for IVAs.
13
Bioavailability of Oral Melatonin in Humans
Franz Waldhauser, Maria Waldhauser, Harris R. Lieberman et al. · Neuroendocrinology · 2008 · 305 citations